筹划重大资产重组！688165 周二复牌

Group 1: Major Announcements - Efort plans to acquire 100% of Shengpu shares and will resume trading on February 10 [1][3][4] - Huatai Medical and other companies plan significant share buybacks [1][5] - Zhenghua Jewelry is under investigation by the CSRC for suspected information disclosure violations [1][6] Group 2: Performance Highlights - Dongwei Technology reports a 2025 net profit increase of 86.81% [1][7] - Weimais shows a 39.22% increase in net profit for 2025 [1][8] - Qianjin Pharmaceutical reports a 24.74% increase in net profit for 2025 [1][9] - City Investment Holdings reports a 19.67% increase in net profit for 2025 [1][10] Group 3: Capital Increases and Restructuring - Hainan Mining plans to acquire 69.90% of Fengrui Fluorine Industry through share issuance and cash payment [1][9] - China National Airlines has received approval for a specific stock issuance [1][10] - Andavil has received approval from the CSRC for a specific stock issuance [1][11] - Yuanjie Technology plans to invest 1.251 billion yuan in a semiconductor chip and device R&D production base [1][20] Group 4: Important Events - Sanbo Brain Science's chairman has been released from investigation [1][12] - Yingfeng Co. adjusts its share buyback price cap to no more than 14.00 yuan per share [1][13] - Yitong Century wins a 1.07 billion yuan project with China Tower [1][15] - China Energy plans to acquire 51% of Fujian Investment Group's pumped storage assets for 864 million yuan [1][18]